LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹48 Cr | ₹38 Cr | ₹57 Cr | ₹72 Cr | ₹130 Cr |
What is the latest Total Debt ratio of LYKA LABS ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹48 Cr |
| Mar2025 | ₹38 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹130 Cr |
How is Total Debt of LYKA LABS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹48 Cr | 27.27 | |
| Mar2025 | ₹38 Cr | -32.99 | |
| Mar2024 | ₹57 Cr | -21.44 | |
| Mar2023 | ₹72 Cr | -44.54 | |
| Mar2022 | ₹130 Cr | - | |
Compare Total Debt of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹308.6 Cr | 6.8% | 1.4% | -7.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 6.8% |
1.4% |
-7.9% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses